Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
CytomX Therapeutics, Inc. has filed 794 SEC EDGAR filings since 28 Sep 2010

SEC filing history

Showing 426-450 of 794 matching filings.

Per page
25
Current page
18
SC 13G/A File 005-89140

SEC SCHEDULE 13G

Filing date
27 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Dec 2019
Reporting date
30 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

2019-11-06 8-K Q3-2019 EARNINGS

Filing date
07 Nov 2019
Reporting date
07 Nov 2019
Next action
Verify source filing
10-Q File 001-37587

10-Q Q3-2019_093019

Filing date
07 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
4

FORM 4

Filing date
16 Oct 2019
Reporting date
15 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
16 Oct 2019
Reporting date
14 Oct 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-37587

2019 10-Q Q2

Filing date
07 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
8-K/A File 001-37587

FORM 8-K AMENDMENT NO. 1

Filing date
21 Jun 2019
Reporting date
19 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

FORM 8-K

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Jun 2019
Reporting date
19 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2019
Reporting date
31 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2019
Reporting date
31 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
04 Jun 2019
Reporting date
31 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
31 May 2019
Reporting date
22 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
29 May 2019
Reporting date
22 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A

Filing date
10 May 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37587

8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .